VANLENT ANNE purchased 23.8% of their position (5K shares) of TREVI THERAPEUTICS, INC. on the open market
Open‑market purchase worth $50.0K — a significant purchase. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 5/13/2019ACC: 0000899243-19-013251
-129.80K
Net shares
Net seller
$50.0K
Total acquired
1
Open market trades
1B · 0S
4
Total transactions
25.98K acquired · 155.78K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+20.98K
Price / share
—
Trade value
—
% of position
New position
5/9/2019
0.00→20.98K
Common Stock
Direct
Shares
+5K
Price / share
$10.00
Trade value
$50K
% of position
23.8%
5/9/2019
20.98K→25.98K
Total
Net shares
+25.98K
Net value
$50K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/9/2019 | C · Conversion | +20.98K | — | — | New position | 0.00 | 20.98K |
| Common Stock Direct | 5/9/2019 | P · Purchase | +5K | $10.00 | $50K | 23.8% | 20.98K | 25.98K |
| Total | +25.98K | $50K | ||||||
Derivative Transactions2
Series A Preferred Stock
Direct
Converts to
Common Stock
15.40K shares
Shares
−107.98K
Strike price
Held after
0.00
Exercisable
—
5/9/2019
Series C Preferred Stock
Direct
Converts to
Common Stock
5.58K shares
Shares
−47.81K
Strike price
Held after
0.00
Exercisable
—
5/9/2019
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Series A Preferred Stock Direct | Common Stock15.40K shares | 5/9/2019 | C · Conversion | −107.98K | — | 0.00 | |
| Series C Preferred Stock Direct | Common Stock5.58K shares | 5/9/2019 | C · Conversion | −47.81K | — | 0.00 |